20 June 2013
Keywords: cpmp, backing, means, lundbeck, moves, close, approval
Article | 25 February 2002
Denmark's Lundbeck is gearing up for a possible launch of its newAlzheimer's disease treatment Ebixa (memantine) in the second half ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 February 2002
19 June 2013
© 2013 thepharmaletter.com